Open AccessHealthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
Author(s) -
Katherine Cappell,
Aliki Taylor,
Barbara H. Johnson,
Steve Gelwicks,
Song Wang,
Michele Gerber,
Daniel A. Leffler
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000000759
Subject(s) - medicine , retrospective cohort study , cohort , comorbidity , health care , charlson comorbidity index , disease , indirect costs , emergency department , emergency medicine , economics , economic growth , accounting , psychiatry , business
Celiac disease (CeD) is a lifelong immune-mediated enteropathy in which dietary gluten triggers an inflammatory reaction in the small intestine. This retrospective cohort study examines healthcare resource utilization (HRU) and costs between patients with CeD and matched controls.